Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
about
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Digital technologies as biomar ...... mer's disease clinical trials.
@en
Digital technologies as biomar ...... mer's disease clinical trials.
@nl
type
label
Digital technologies as biomar ...... mer's disease clinical trials.
@en
Digital technologies as biomar ...... mer's disease clinical trials.
@nl
prefLabel
Digital technologies as biomar ...... mer's disease clinical trials.
@en
Digital technologies as biomar ...... mer's disease clinical trials.
@nl
P2093
P2860
P1476
Digital technologies as biomar ...... imer's disease clinical trials
@en
P2093
Bradley B Miller
Gabriel Vargas
Holly Soares
Ioannis Tarnanas
J Jeremy Rice
James A Hendrix
Jesse M Cedarbaum
Joan Amatniek
Lisa J Bain
Maria B Tome
P2860
P304
P356
10.1016/J.TRCI.2018.04.003
P577
2018-05-24T00:00:00Z